RankingsPricing
  1. US-listed companies
  2. INSMED Inc
  3. Financials
  4. Cash from investing

INSMED IncINSM

Market cap
$41.3B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024-583+160.81%
Dec 31, 2023-224+546.55%
Dec 31, 2022-35-46.20%
Dec 31, 2021-64+842.32%
Dec 31, 2020-7-83.86%
Dec 31, 2019-42+185.32%
Dec 31, 2018-15+393.64%
Dec 31, 2017-3-28.55%
Dec 31, 2016-4+21.60%
Dec 31, 2015-3-35.33%
Dec 31, 2014-5-501.88%
Dec 31, 20131-97.84%
Dec 31, 201262+79.05%
Dec 31, 201134

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)